Global Pediatric Genetic Testing Market Research Report: Forecast (2023-2028)

Name: Global Pediatric Genetic Testing Market Research Report: Forecast (2023-2028)
Creator: MarkNtel Advisors
License: https://www.marknteladvisors.com/privacy-policy

By Product Type (Kits, Reagents, Laboratory Developed Tests [LDT]), By Sample Type (Saliva, Blood, Tissue, Bone Marrow), By Technology (Next Generation Sequencing, Fluorescent In S...itu Hybridization [FISH], Polymerase Chain Reaction, Microarray Techniques, Others), By Disorder (Developmental Disorders, Cardiovascular Disorders, Neurological Disorders, Others), By Application (Clinical Diagnostics, Drug Discovery, Monitoring and Screening, Academic and Research), By Origin (Inherited Disorders, Somatic Disorders), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Company (Abbott Laboratories, BGI Genomics, Invitae Corporation, Trivitron Healthcare, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Quest Diagnostics, Unilabs Group Services, Agilent Technologies, Inc., Genomic Diagnostics, PerkinElmer, Inc., CENTOGENE N.V, OPKO Health, Inc., Baebies, Inc., Eurofins Scientific) Read more

Healthcare
Apr 2023
Pages 211
Report Format: PDF, Excel, PPT

Get Actionable Insights for Smarter Decisions: Regional and country reports in one place pick a location for insights and Trends.

Market Definition

A form of medical analysis known as pediatric genetic testing scans for alterations in a child's genes, chromosomes, or proteins. It is used to determine the presence of genetic disorders or congenital disabilities & to estimate the likelihood of an infection being passed on to future generations.

Genetic tests can also be used to identify some diseases and to predict how a condition will develop. The value of pediatric genetic testing resides in its capacity to identify and classify illnesses at an early stage when therapies are still conceivable.

Market Insights & Analysis: Global Pediatric Genetic Testing Market (2023-28)

The Global Pediatric Genetic Testing Market is projected to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28. Growing consciousness regarding the benefits of pediatric genetic testing stemming from the increasing prevalence of genetic disorders in children over the past few years has encouraged market expansion in the historical years. Other than this, the snowballing demand for personalized medicine and targeted therapies combined with technological developments in platforms and methodologies for genetic testing are likely to bode well for the industry in the long run.

Moreover, Molecular testing identifies patients more vulnerable to cancer and other diseases, which aids surveillance. This allows for pre-symptomatic diagnosis & gives enough lead time to stop the progression. Given these benefits, such testing methods are highly incorporated, consequently enhancing Global Pediatric Genetic Testing Market size during the forecast period.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
CAGR (2023-2028)	14%
Regions Covered	North America: The US, Canada, Mexico
	Europe: UK, Germany, France, Spain, Italy, and Others
	Asia-Pacific: China, India, Japan, South Korea, Australia, and Others
	South America: Brazil, and Others
	Middle East & Africa: UAE, Saudi Arabia, South Africa, and Others
Key Companies Profiled	Abbott Laboratories, BGI Genomics, Invitae Corporation, Trivitron Healthcare, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Quest Diagnostics, Unilabs Group Services, Agilent Technologies, Inc., Genomic Diagnostics, PerkinElmer, Inc., CENTOGENE N.V, OPKO Health, Inc., Baebies, Inc., Eurofins Scientific etc.
Unit Denominations	USD Million/Billion

Similarly, the influx of investment in the market, constantly upscaled by the growing number of private-sector players, is likely to inflate the revenue shares in the coming period. For instance, in July 2021, Avellino Laboratories announced the introduction of AvaGen, the genetic eye test, in the United States. The test help patients evaluate their risk of developing keratoconus and other corneal dystrophies. Thus, the industry is projected to expand as a result of these initiatives by significant market participants.

Market Dynamics

Key Driver: Ever-Increasing Demand for Molecular Testing to Diagnose Cancer

Molecular tests verify the diagnosis, project a prognosis and help formulate a treatment plan for children who have cancer or showing the risk of developing cancer. Besides, they play a crucial role in providing genetic counseling and prenatal diagnosis to the family as well. Owing to the potential benefits of molecular testing in diagnosing cancer and enabling people to make informed decisions about managing their children's health care have encouraged the incorporation of genetic-based tests over the course of time, accelerating the market forward.

Possible Restraint: Ethical Implications of Using DNA-based Tests in Clinical Settings

In addition to being technically tricky, DNA-based diagnostics also pose several moral issues with regard to the indications, interpretation, and ramifications for the patient and family. Concerns regarding morality, the legality of the request, and the impact on children's mental well-being followed by the increased adoption of such genetic testing might discourage its incorporation in the long run. Furthermore, the variety of tests available for various purposes and the lack of studies looking at the long-term effects of testing on children have made it difficult to provide guidelines. Considering this, the indications provided by some tests have proven benefits over harms, while others have less clear justification.

Growth Opportunity: Large-scale Adoption of Sustainable & High-performance Pediatric Genetic Testing Materials

The increasing use of cutting-edge technology and materials to improve the performance of pediatric genetic testing devices is one of the market's key trends. To increase the robustness, effectiveness, and security of Pediatric Genetic Testing goods, technologies like smart sensors and advanced coatings, combined with novel production techniques, have been incorporated. As a result, demand for high-performance Pediatric Genetic Testing materials is anticipated to increase in the upcoming years.

In addition, the growing emphasis on sustainability and environmental consciousness is another trend boosting the market for pediatric genetic testing. By utilizing green products and resources, many businesses are attempting to lessen their impact on the environment. This, in turn, is likely to open up new avenues for companies that specialize in developing sustainable Pediatric Genetic Testing solutions.

Key Trend: Constant Technological Developments in Genetic Testing Worldwide

Technology advancements have made it possible for doctors to do tests more accurately and to examine numerous pieces of genetic data simultaneously. Moreover, by approving the new ways of testing, many countries are facilitating their adoption. For instance, the United States Food and Drug Administration approved the first test to identify Fragile X Syndrome (FXS), one of the primary causes of inherited developmental delay and intellectual disability, in February 2021. Thus, the rising burden of chronic diseases paired with technological improvements has furthered market expansion in the historical period.

Market Segmentation

Based on Disorder,

Developmental Disorders
Cardiovascular Disorders
Neurological Disorders
Others

Cardiovascular Disorders is expected to grow at the highest CAGR by 2028 in the Global Pediatric Genetic Testing market, being one of the major causes of death globally, with an estimated 17.9 million lives each year. Genetic testing is informative and helpful for managing various inherited cardiovascular diseases such as thoracic aortic aneurysms and dissections, cardiomyopathies, arrhythmic disorders, and familial hypercholesterolemia (FH). Therefore, the burgeoning incidences of cardiovascular diseases, a rising number of obesity cases, and a surging degree of a sedentary lifestyle are anticipated to increase the risk of inheritance, necessitating effective pediatric genome testing and, in turn, driving the growth of the market globally.

Regional Projection

Geographically, the Global Pediatric Genetic Testing Market expands across:

North America
South America
Europe
Middle East & Africa
Asia-Pacific

Among other regions, North America is projected to witness significant growth in terms of revenue share during the forecast period. It can be attributed to a number of factors, including the existence of a well-established healthcare infrastructure, a high adoption rate for cutting-edge diagnostic technology, and a growing emphasis on research to advance pediatric treatment, particularly cancer-specific. For instance, In March 2022, the National Cancer Institute launched the Molecular Characterization Initiative for pediatric tumors in line with the USA's Cancer Moonshot goal of encouraging data sharing in cancer research.

Recent Developments

In December 2022, one of the leading medical genetics businesses, Invitae Corporation, announced the introduction of the Rare Patient Network, which expands Invitae's Citizen platform to all children with pediatric epilepsy and developmental delay. Invitae, a pioneer in rare pediatric neurodevelopmental disorders, wants to benefit much more sufferers of rare diseases by interacting with a larger community.

Gain a Competitive Edge with Our Global Pediatric Genetic Testing Market Report

Global Pediatric Genetic Testing Market Report by Markntel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
Global Pediatric Genetic Testing Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

Frequently Asked Questions

A. The Pediatric Genetic Testing Market is projected to grow at a CAGR of around 14% during 2023-28.

A. Rise in the demand for genetic testing to diagnose cancer is expected to drive the pediatric genetic testing market during 2023-28.

A. Abbott Laboratories, BGI Genomics, Invitae Corporation, Trivitron Healthcare, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc., Quest Diagnostics, Unilabs Group Services, Agilent Technologies, Inc., Genomic Diagnostics, PerkinElmer, Inc., CENTOGENE N.V, OPKO Health, Inc., Baebies, Inc., Eurofins Scientific are the top players in the Pediatric Genetic Testing Market.

A. Cardiovascular disorder is anticipated to emerge as an area of remunerative opportunities for the leading players in the Pediatric Genetic Testing market.

A. Globally, North America would provide lucrative prospects for the pediatric genetic testing market in the years ahead.

A. Technological developments in genetic testing is the key trend shaping the growth of the Pediatric Genetic Testing market.

A. Large-scale adoption of sustainable and high-performance pediatric genetic testing materials are the growth opportunities for the market players through 2028.

A. Ethical implications of using DNA-based tests in clinical settings are the possible restraint affecting the growth of the market.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
4. Market Segmentation
Preface
Executive Summary
Global Pediatric Genetic Testing Market Overview
Impact of COVID-19 on Global Pediatric Genetic Testing Market
Global Pediatric Genetic Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product Type
    1. Kits
    2. Reagents
    3. Laboratory Developed Tests (LDT)
  2. By Sample Type
    1. Saliva
    2. Blood
    3. Tissue
    4. Bone Marrow
  3. By Technology
    1. Next Generation Sequencing
    2. Fluorescent In Situ Hybridization (FISH)
    3. Polymerase Chain Reaction
    4. Microarray Techniques
    5. Others
  4. By Disorder
    1. Developmental Disorders
    2. Cardiovascular Disorders
    3. Neurological Disorders
    4. Others
  5. By Application
    1. Clinical Diagnostics
    2. Drug Discovery
    3. Monitoring and Screening
    4. Academic and Research
  6. By Origin
    1. Inherited Disorders
    2. Somatic Disorders
  7. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  8. By Competitors
    1. Competition Characteristics
    2. Market Share & Analysis
    3. Competitive Metrix
North America Pediatric Genetic Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product Type
  2. By Sample Type
  3. By Technology
  4. By Disorder
  5. By Application
  6. By Origin
  7. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
4. Canada Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
5. Mexico Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
South America Pediatric Genetic Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product Type
  2. By Sample Type
  3. By Technology
  4. By Disorder
  5. By Application
  6. By Origin
  7. By Country
    1. Brazil
    2. Others
3. Brazil Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
Europe Pediatric Genetic Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product Type
  2. By Sample Type
  3. By Technology
  4. By Disorder
  5. By Application
  6. By Origin
  7. By Country
    1. Germany
    2. The UK
    3. France
    4. Italy
    5. Spain
    6. Others
3. Germany Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
4. The UK Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
5. France Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
6. Italy Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
7. Spain Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
Middle East & Africa Pediatric Genetic Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product Type
  2. By Sample Type
  3. By Technology
  4. By Disorder
  5. By Application
  6. By Origin
  7. By Country
    1. UAE
    2. Saudi Arabia
    3. South Africa
    4. Others
3. UAE Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
4. Saudi Arabia Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
5. South Africa Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
Asia-Pacific Pediatric Genetic Testing Market Outlook, 2018-2028F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Product Type
  2. By Sample Type
  3. By Technology
  4. By Disorder
  5. By Application
  6. By Origin
  7. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. Others
3. China Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
4. India Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
5. Japan Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
6. South Korea Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
7. Australia Pediatric Genetic Testing Market Outlook, 2018-2028F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Product Type
    2. By Application
Global Pediatric Genetic Testing Market Regulations, Policies, Product Benchmarks, By Region
1. The United States
2. European Union
  1. Germany
  2. The UK
  3. France
  4. Italy
3. Asia Pacific
  1. China
  2. Japan
  3. South Korea
Global Pediatric Genetic Testing Market Intellectual Property Rights Analysis
Global Pediatric Genetic Testing Market Trends & Insights
Global Pediatric Genetic Testing Market Dynamics
1. Drivers
2. Challenges
3. Impact Analysis
Global Pediatric Genetic Testing Market Hotspot & Opportunities
Global Pediatric Genetic Testing Market, Competition Outlook
1. Competition Matrix
  1. Target Markets
  2. Target Applications
  3. Research & Development
  4. Collaborations & Strategic Alliances
  5. Key Business Expansion Initiatives
  6. Business Restructuring- Mergers, Acquisitions, JVs
  7. Strategic Initiatives
2. Company Profiles (Business Description, Product Offering, Strategic Alliances or Partnerships, etc.)
  1. Abbott Laboratories
  2. BGI Genomics
  3. Invitae Corporation
  4. Trivitron Healthcare
  5. Thermo Fisher Scientific Inc.
  6. Fulgent Genetics, Inc.
  7. Quest Diagnostics
  8. Unilabs Group Services
  9. Agilent Technologies, Inc.
  10. Genomic Diagnostics
  11. PerkinElmer, Inc.
  12. CENTOGENE N.V
  13. OPKO Health, Inc.
  14. Baebies, Inc.
  15. Eurofins Scientific
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying